In-silico ADMET profile of Ellagic Acid from Syzygium cumini: A Natural Biaryl Polyphenol with Therapeutic Potential to Overcome Diabetic Associated Vascular Complications
Abstract
Plant Based Natural Products (PBNPs) are the primary source of natural antioxidants capable of neutralizing or eliminating harmful Reactive Oxygen Species (ROS). Oxidative stress contributes not only to the pathogenesis of type 2 diabetes (T2DM) but also to diabetic related vascular complications by lipid peroxidation. Oxidation induced DNA and protein damage leads to development of vascular complications like coronary heart disease, CVD, stroke, neuropathy, retinopathy, nephropathy, CKD, and other long term complications associated with diabetics. Likewise Multidrug resistance (MDR) is one of the major clinical challenges in cancer treatment and compromises the effectiveness of conventional anticancer chemotherapeutics. P-glycoprotein (P-gp) has been characterized as a major mechanism of MDR. Ellagic acid (EA) is a bioactive secondary metabolite widely distributed in vegetables and fruits (Strawberry, Grapes, Blackberry, Raspberry, Plums etc.) Chemically, EA is 2,3,7,8-tetrahydroxychromeno [5,4, -cde] chromene-5, 10-dione, a heterotetracyclic dimer of Gallic Acid (GA) molecules formed by oxidative aromatic coupling involving intramolecular lactonization. EA is associated with pharmacological activities such as anti-inflammatory, neuroprotective, cardio-protective, antioxidant, anti-mutagenic, multidrug resistance etc. EA has been marketed as a dietary supplement with claimed benefits against cancer, CVD, CKD and other metabolic disorders. However, pharmacological limitation of EA is attributed to its low solubility in water and reduced bioavailability. In the present study, bimolecular potential of EA has been bioprospected in the revised framework of ADMET pharmacoinformatics to further widen its biomedical applications.
Keywords: ADMET; Pharmacoinformatics; Ellagic Acid; Gallic Acid; Syzygium cumini; Alagarkovil Reserve Forest (ARF); Reactive Oxygen Species (ROS)
Downloads
References
Agrawal OD, Kulkarni YA. Mini-Review of Analytical Methods used in Quantification of Ellagic Acid. Reviews in Analytical Chemistry. 2020; 39(1):31-44. https://doi.org/10.1515/revac-2020-0113
Gajera HP, Gevariya SN, Hirpara DG, Patel SV, Golakiya BA. Antidiabetic and antioxidant functionality associated with phenolic constituents from fruit parts of indigenous black jamun (Syzygium cumini L.) landraces. J Food Sci Technol 2017; 54:3180-3191 https://doi.org/10.1007/s13197-017-2756-8
Meyer AS, Heinonen M, Frankel EN. Antioxidant Interactions of Catechin, Cyanidin, Caffeic acid, Quercetin, and Ellagic acid on Human LDL Oxidation. Food Chem. 1998; 61(1-2):71-5. https://doi.org/10.1016/S0308-8146(97)00100-3
Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free Radical Studies of Ellagic acid, a Natural Phenolic Antioxidant. J Agric Food Chem. 2002; 50(7):2200-6. https://doi.org/10.1021/jf011275g
Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, et al. In Vitro Antiproliferative, Apoptotic and Antioxidant Activities of Punicalagin, Ellagic acid and a Total Pomegranate Tannin Extract Are Enhanced in Combination with Other Polyphenols as Found in Pomegranate Juice. J Nutr Biochem. 2005; 16(6):360-7. https://doi.org/10.1016/j.jnutbio.2005.01.006
Hussein MZ, Al Ali SH, Zainal Z, Hakim MN. Development of Antiproliferative Nanohybrid Compound with Controlled Release Property Using Ellagic acid as the Active Agent. Int J Nanomedicine. 2011; 6(1):1373-83. https://doi.org/10.2147/IJN.S21567
Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, et al. In Vitro and In Vivo Properties of Ellagic acid in Malaria Treatment. Antimicrob Agents Chemother. 2009; 53(3):1100-6. https://doi.org/10.1128/AAC.01175-08
Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. Evaluation of the Anti-Inflammatory Effects of Ellagic acid. J Perianesth Nurs. 2010; 25(4):214-20. https://doi.org/10.1016/j.jopan.2010.05.011
García-Niño WR, Zazueta C. Ellagic acid: Pharmacological Activities and Molecular Mechanisms Involved in Liver Protection. Pharmacol Res. 2015; 97:84-103. https://doi.org/10.1016/j.phrs.2015.04.008
Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF. The Effects of Dietary Ellagic acid on Rat Hepatic and Esophageal Mucosal Cytochromes P450 and Phase II Enzymes. Carcinogenesis. 1996; 17(4):821-8. https://doi.org/10.1093/carcin/17.4.821
Umesalma S, Sudhandiran G. Differential Inhibitory Effects of the Polyphenol Ellagic acid on Inflammatory Mediators NF-KB, INOS, COX-2, TNF-α, and IL-6 in 1,2-Dimethylhydrazine-Induced Rat Colon Carcinogenesis. Basic Clin Pharmacol Toxicol. 2010; 107(2):650-5. https://doi.org/10.1111/j.1742-7843.2010.00565.x
Chen GH, Lin YL, Hsu WL, Hsieh SK, Tzen JT. Significant Elevation of Antiviral Activity of Strictinin from Pu'er Tea after Thermal Degradation to Ellagic acid and Gallic acid. Yao Wu Shi Pin Fen Xi. 2015; 23(1):116-23. https://doi.org/10.1016/j.jfda.2014.07.007
Park SW, Kwon MJ, Yoo JY, Choi HJ, Ahn YJ. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa Leaves toward Human Rhinoviruses. BMC Complement Altern Med. 2014; 14(1):171. https://doi.org/10.1186/1472-6882-14-171
Evtyugin DD, Magina S, Evtuguin DV. Recent advances in the production and applications of ellagic acid and its derivatives. A review. Molecules. 2020 Jan; 25(12):2745. https://doi.org/10.3390/molecules25122745
Alfei S, Turrini F, Catena S, Zunin P, Grilli M, Pittaluga AM, Boggia R. Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review. European journal of medicinal chemistry. 2019 Dec 1; 183:111724. https://doi.org/10.1016/j.ejmech.2019.111724
Kumar Singh A, Cabral C, Kumar R, Ganguly R, Kumar Rana H, Gupta A, Rosaria Lauro M, Carbone C, Reis F, Pandey AK. Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency. Nutrients. 2019 Sep; 11(9):2216. https://doi.org/10.3390/nu11092216
Zhang, H.; Xu, H.; Ashby, C.R., Jr.; Assaraf, Y.G.; Chen, Z.S.; Liu, H.M. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Med. Res. Rev. 2021, 41, 525-555. https://doi.org/10.1002/med.21739
Yoganathan S, Alagaratnam A, Acharekar N, Kong J. Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer. Cells. 2021 Feb; 10(2):458. https://doi.org/10.3390/cells10020458
Gupta A, Singh AK, Kumar R, Jamieson S, Pandey AK, Bishayee A. Neuroprotective Potential of Ellagic Acid: A Critical Review. Advances in Nutrition. 2021:1-28; doi: https://doi.org/10.1093/advances/nmab007
Ríos JL, Giner RM, Marín M, Recio MC. A pharmacological update of ellagic acid. Planta medica. 2018 Oct; 84(15):1068-93. https://doi.org/10.1055/a-0633-9492
Ruan ZP, Zhang LL, Lin YM. Evaluation of the antioxidant activity of Syzygium cumini leaves. Molecules. 2008; 13(10):2545-56 https://doi.org/10.3390/molecules13102545
Ahmed R, Tariq M, Hussain M, Andleeb A, Masoud MS, Ali I, Mraiche F, Hasan A. Phenolic contents-based assessment of therapeutic potential of Syzygium cumini leaves extract. PloS one 2019; 14(8):e0221318 https://doi.org/10.1371/journal.pone.0221318
Aqil F, Gupta A, Munagala R, Jeyabalan J, Kausar H, Sharma RJ Antioxidant and antiproliferative activities of anthocyanin/ ellagitannin-enriched extracts from Syzygium cumini L.(Jamun, the Indian Blackberry). Nutrition and Cancer 2012; 64(3):428-38 https://doi.org/10.1080/01635581.2012.657766
Ayyappan P, Ganesan K, Jayakumararaj R Ethnobotanic information on uncommon anti-diabetic medicinal plants from Alagarkoil Forest Reserve: Evidence based strategic rationale in management of diabetics. Int J Pharm Res 2019; 16:515-26
Ramya S, Neethirajan K, Jayakumararaj R. Profile of bioactive compounds in Syzygium cumini-a review. J. Pharm. Res 2012; 5(8):4548-4553
Loganathan T, Barathinivas A, Soorya C, Balamurugan S, Nagajothi TG, Jayakumararaj R. GCMS Profile of Bioactive Secondary Metabolites with Therapeutic Potential in the Ethanolic Leaf Extracts of Azadirachta indica¬: A Sacred Traditional Medicinal Plant of INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(4-S):119-26. https://doi.org/10.22270/jddt.v11i4-S.4967
Soorya C, Balamurugan S, Basha AN, Kandeepan C, Ramya S, Jayakumararaj R. Profile of Bioactive Phyto-compounds in Essential Oil of Cymbopogon martinii from Palani Hills, Western Ghats, INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(4):60-5. https://doi.org/10.22270/jddt.v11i4.4887
Soorya C, Balamurugan S, Ramya S, Neethirajan K, Kandeepan C, Jayakumararaj R. Physicochemical, ADMET and Druggable properties of Myricetin: A Key Flavonoid in Syzygium cumini that regulates metabolic inflammations. Journal of Drug Delivery and Therapeutics. 2021 Jul 15; 11(4):66-73 https://doi.org/10.22270/jddt.v11i4.4890
Sabitha, M., Krishnaveni, K., Murugan, M., Basha, A.N., Pallan, G.A., Kandeepan, C., Ramya, S. and Jayakumararaj, R., In-silico ADMET predicated Pharmacoinformatics of Quercetin-3-Galactoside, polyphenolic compound from Azadirachta indica, a sacred tree from Hill Temple in Alagarkovil Reserve Forest, Eastern Ghats, INDIA. Journal of Drug Delivery and Therapeutics, 2021; 11(5-S):77-84 https://doi.org/10.22270/jddt.v11i5-S.5026
Loganathan T, Barathinivas A, Soorya C, Balamurugan S, Nagajothi TG, Ramya S, Jayakumararaj R. Physicochemical, Druggable, ADMET Pharmacoinformatics and Therapeutic Potentials of Azadirachtin-a Prenol Lipid (Triterpenoid) from Seed Oil Extracts of Azadirachta indica A. Juss. Journal of Drug Delivery and Therapeutics. 2021; 11(5):33-46. https://doi.org/10.22270/jddt.v11i5.4981
Kandeepan C, Kalaimathi RV, Jeevalatha A, Basha AN, Ramya S, Jayakumararaj R. In-silico ADMET Pharmacoinformatics of Geraniol (3, 7-dimethylocta-trans-2, 6-dien-1-ol)-acyclic monoterpene alcohol drug from Leaf Essential Oil of Cymbopogon martinii from Sirumalai Hills (Eastern Ghats), INDIA. Journal of Drug Delivery and Therapeutics. 2021; 11(4-S):109-18. https://doi.org/10.22270/jddt.v11i4-S.4965
Liu, R., and A. Wallqvist. Merging applicability domains for in silico assessment of chemical mutagenicity. Journal of Chemical Information and Modeling. 2014; 54(3):793-800 https://doi.org/10.1021/ci500016v
Liu, R., G. Tawa, and A. Wallqvist. Locally weighted learning methods for predicting dose-dependent toxicity with application to the human maximum recommended daily dose. Chemical Research in Toxicology. 2012; 25(10):2216-2226 https://doi.org/10.1021/tx300279f
Liu, R., P. Schyman, and A. Wallqvist. Critically assessing the predictive power of QSAR models for human liver microsomal stability. Journal of Chemical Information and Modeling. 2015; 55(8):1566-1575 https://doi.org/10.1021/acs.jcim.5b00255
Schyman P., R. Liu, V. Desai, and A. Wallqvist. vNN web server for ADMET predictions. Frontiers in Pharmacology. 2017 December 4; 8:889 https://doi.org/10.3389/fphar.2017.00889
Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clinica Chimica Acta. 2004 Oct 1; 348(1-2):63-8. https://doi.org/10.1016/j.cccn.2004.04.029
Dharani J, Ravi S. in silico ADMET Screening of Compounds Present in Cyanthillium cinereum (L.) H. Rob. Asian Journal of Chemistry. 2020; 32(6):1421-6. https://doi.org/10.14233/ajchem.2020.22569
Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RB, Aparna SR, Mangalapandi P, Samal A. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Scientific Reports. 2018; 8(1):1-7. https://doi.org/10.1038/s41598-018-22631-z
Liu T, Oprea T, Ursu O, Hasselgren C, Altman RB. Estimation of maximum recommended therapeutic dose using predicted promiscuity and potency. Clinical and translational science. 2016 Dec; 9(6):311-20. https://doi.org/10.1111/cts.12422
Schyman, P., R. Liu, and A. Wallqvist. General purpose 2D and 3D similarity approach to identify hERG blockers. Journal of Chemical Information and Modelling. 2016; 56(1):213-222 https://doi.org/10.1021/acs.jcim.5b00616
Plonka W, Stork C, Šícho M, Kirchmair J. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes. Bioorganic & Medicinal Chemistry. 2021; 46:116388. https://doi.org/10.1016/j.bmc.2021.116388
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports. 2017 Mar 3; 7(1):1-3. https://doi.org/10.1038/srep42717
Daina A, Zoete V. A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016 Jun 6; 11(11):1117. https://doi.org/10.1002/cmdc.201600182
Li, D., L. Chen, Y. Li, S. Tian, H. Sun, and T. Hou. ADMET evaluation in drug discovery. 13. Development of in Silico prediction models for P-Glycoprotein substrates. 2014; 11(3):716-726 https://doi.org/10.1021/mp400450m
Broccatelli, F., E. Carosati, A. Neri, M. Frosini, L. Goracci, T. Oprea, and G. Cruciani. A novel approach for predicting P-Glycoprotein (ABCB1) inhibition using molecular interaction fields. 2011; 54(6):1740-1751. https://doi.org/10.1021/jm101421d
Chen, L., Y. Li, Q. Zhao, H. Peng, and T. Hou. ADME evaluation in drug discovery. 10. Predictions of P-Glycoprotein inhibitors using recursive partitioning and naive bayesian classification techniques. 2011; 8(3):889-900 https://doi.org/10.1021/mp100465q
Schyman, P., R. Liu, and A. Wallqvist. Using the variable-nearest neighbour method to identify P-glycoprotein substrates and inhibitors. ACS Omega. 2016; 1(5):923-929 https://doi.org/10.1021/acsomega.6b00247
Attene-Ramos, M., R. Huang, S. Michael, K. Witt, A. Richard, R. Tice, A. Simeonov, C. Austin, M. Xia. Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. 2015; 123(1):49. https://doi.org/10.1289/ehp.1408642
Naef R. A generally applicable computer algorithm based on the group additivity method for the calculation of seven molecular descriptors: Heat of combustion, LogPO/W, LogS, refractivity, polarizability, toxicity and LogBB of organic compounds; scope and limits of applicability. Molecules 2015; 20(10):18279-351 https://doi.org/10.3390/molecules201018279
Zhou Y, Wu F, Li L, Shen X, Chen G, Wang X, Liang X, Tan M, Huang Z. Computational approaches in preclinical studies on drug discovery and development. Frontiers in Chemistry. 2020; 8:726-31. https://doi.org/10.3389/fchem.2020.00726
Kong M, Xie K, Lv M, Li J, Yao J, Yan K, Wu X, Xu Y, Ye D. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomedicine & Pharmacotherapy. 2021; 133:110975. https://doi.org/10.1016/j.biopha.2020.110975
Alfei S, Marengo B, Zuccari G. Oxidative stress, antioxidant capabilities, and bioavailability: Ellagic acid or urolithins?. Antioxidants. 2020 Aug; 9(8):707. https://doi.org/10.3390/antiox9080707
Copyright (c) 2022 S. Ramya, M. Murugan, K. Krishnaveni, M. Sabitha, C. Kandeepan, R. Jayakumararaj
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 